NEW YORK (AP) — NEW YORK (AP) — Neurogene Inc. (NGNE) on Tuesday reported a loss of $24.7 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of $1.12.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.

For the year, the company reported a loss of $90.4 million, or $4.24 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGNE at https://www.zacks.com/ap/NGNE

Source